These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 36165188)
1. Changes in health harms due to cannabis following legalisation of non-medical cannabis in Canada in context of cannabis commercialisation: A scoping review. Myran DT; Imtiaz S; Konikoff L; Douglas L; Elton-Marshall T Drug Alcohol Rev; 2023 Feb; 42(2):277-298. PubMed ID: 36165188 [TBL] [Abstract][Full Text] [Related]
2. Access to legal cannabis market in Canada over the four years following non-medical cannabis legalisation. Myran DT; Friesen EL; Dickson S; Konikoff L; Arora G; Tanuseputro P Drug Alcohol Rev; 2023 Jul; 42(5):1114-1119. PubMed ID: 36933893 [TBL] [Abstract][Full Text] [Related]
3. How has access to legal cannabis changed over time? An analysis of the cannabis retail market in Canada 2 years following the legalisation of recreational cannabis. Myran DT; Staykov E; Cantor N; Taljaard M; Quach BI; Hawken S; Tanuseputro P Drug Alcohol Rev; 2022 Feb; 41(2):377-385. PubMed ID: 34250645 [TBL] [Abstract][Full Text] [Related]
4. Availability, retail price and potency of legal and illegal cannabis in Canada after recreational cannabis legalisation. Mahamad S; Wadsworth E; Rynard V; Goodman S; Hammond D Drug Alcohol Rev; 2020 May; 39(4):337-346. PubMed ID: 32291811 [TBL] [Abstract][Full Text] [Related]
5. Legal cannabis market shares during Canada's first year of recreational legalisation. Armstrong MJ Int J Drug Policy; 2021 Feb; 88():103028. PubMed ID: 33221614 [TBL] [Abstract][Full Text] [Related]
6. Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, concepts and considerations. Fischer B; Daldegan-Bueno D; Boden JM Drug Alcohol Rev; 2020 Jul; 39(5):555-567. PubMed ID: 32436274 [TBL] [Abstract][Full Text] [Related]
7. Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA. Chiu V; Leung J; Hall W; Stjepanović D; Degenhardt L Neuropharmacology; 2021 Aug; 193():108610. PubMed ID: 34010617 [TBL] [Abstract][Full Text] [Related]
8. Adverse outcomes of cannabis use in Canada, before and after legalisation of non-medical cannabis: cross-sectional analysis of the International Cannabis Policy Study. Marquette A; Iraniparast M; Hammond D BMJ Open; 2024 Jan; 14(1):e077908. PubMed ID: 38171626 [TBL] [Abstract][Full Text] [Related]
9. Guidelines for public health and safety metrics to evaluate the potential harms and benefits of cannabis regulation in Canada. Lake S; Kerr T; Werb D; Haines-Saah R; Fischer B; Thomas G; Walsh Z; Ware MA; Wood E; Milloy MJ Drug Alcohol Rev; 2019 Sep; 38(6):606-621. PubMed ID: 31577059 [TBL] [Abstract][Full Text] [Related]
10. Public health implications of legalising the production and sale of cannabis for medicinal and recreational use. Hall W; Stjepanović D; Caulkins J; Lynskey M; Leung J; Campbell G; Degenhardt L Lancet; 2019 Oct; 394(10208):1580-1590. PubMed ID: 31657733 [TBL] [Abstract][Full Text] [Related]
11. Le marché légal du cannabis suite à sa légalisation au Canada : pistes de réflexion pour un encadrement efficace. Patenaude C; Brochu S; Fallu JS; Jutras-Aswad D; D'Arcy L Can J Public Health; 2018 Apr; 109(2):215-218. PubMed ID: 29981041 [TBL] [Abstract][Full Text] [Related]
12. Cannabis legalisation: should doctors be concerned? Kanniah G; Kumar S N Z Med J; 2021 Jun; 134(1537):84-90. PubMed ID: 34239164 [TBL] [Abstract][Full Text] [Related]
13. Social and public health implications of the legalisation of recreational cannabis: A literature review. Mokwena K Afr J Prim Health Care Fam Med; 2019 Nov; 11(1):e1-e6. PubMed ID: 31793317 [TBL] [Abstract][Full Text] [Related]
14. Patterns of problematic cannabis use in Canada pre- and post-legalisation: Differences by neighbourhood deprivation, individual socioeconomic factors and race/ethnicity. Fataar F; Driezen P; Owusu-Bempah A; Hammond D Drug Alcohol Rev; 2023 Sep; 42(6):1534-1546. PubMed ID: 37137866 [TBL] [Abstract][Full Text] [Related]
15. Impact of the legalisation of recreational cannabis use. Isorna M; Pascual F; Aso E; Arias F Adicciones; 2023 Sep; 35(3):349-376. PubMed ID: 35472157 [TBL] [Abstract][Full Text] [Related]
16. Geographic clustering of cannabis stores in Canadian cities: A spatial analysis of the legal cannabis market 4 years post-legalisation. Friesen EL; Konikoff L; Dickson S; Myran DT Drug Alcohol Rev; 2024 Nov; 43(7):1753-1763. PubMed ID: 38803128 [TBL] [Abstract][Full Text] [Related]
17. Disparities in cannabis-related emergency department visits across depressed and non-depressed individuals and the impact of recreational cannabis policy in Ontario, Canada. Kim C; Dusing GJ; Nielsen A; MacMaster FP; Rittenbach K; Allin S; O'Campo P; Penney TL; Hamilton HA; Kirst M; Chum A Psychol Med; 2023 Nov; 53(15):7127-7137. PubMed ID: 37345465 [TBL] [Abstract][Full Text] [Related]
18. Effects of cannabis legalisation on patterns of cannabis consumption among adolescents in Ontario, Canada (2001-2019). Imtiaz S; Nigatu YT; Sanches M; Ali F; Boak A; Douglas L; Hamilton HA; Rehm J; Rueda S; Schwartz RM; Wells S; Elton-Marshall T Drug Alcohol Rev; 2024 Mar; 43(3):764-774. PubMed ID: 38015010 [TBL] [Abstract][Full Text] [Related]
19. Impact of Canada's cannabis legalisation on youth emergency department visits for cannabis-related disorders and poisoning in Ontario and Alberta, 2015-2019. Callaghan RC; Sanches M; Vander Heiden J; Kish SJ Drug Alcohol Rev; 2023 Jul; 42(5):1104-1113. PubMed ID: 36908258 [TBL] [Abstract][Full Text] [Related]
20. Relationships between increases in Canadian cannabis stores, sales, and prevalence. Armstrong MJ Drug Alcohol Depend; 2021 Nov; 228():109071. PubMed ID: 34592703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]